3Z Pharmaceuticals Reveals Revolutionary Insights on Metabolic Pathways in ADHD Treatments 3Z Pharmaceuticals has published a significant study in The Journal of Pharmacology, uncovering shared metabolic pathways in ADHD therapeutics.

3Z Pharmaceuticals Reveals Revolutionary Insights on Metabolic Pathways in ADHD Treatments #Iceland #Reykjavik #Metabolomics #ADHD_Therapy #3Z_Pharmaceuticals

3Z Pharmaceuticals Introduces Revolutionary Study on Calcium Channel Blockers for ADHD Treatment 3Z Pharmaceuticals has released a groundbreaking study demonstrating the potential of amlodipine, a calcium channel blocker, as a new non-stimulant therapy for ADHD.

3Z Pharmaceuticals Introduces Revolutionary Study on Calcium Channel Blockers for ADHD Treatment #Iceland #Reykjavik #ADHD_Therapy #Amlodipine #3Z_Pharmaceuticals